ACH Accendra Health, Inc.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.…
Industry Peers
Medical DistributionKey Statistics
About Accendra Health (NYSE: ACH)
›
Accendra Health (NYSE: ACH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 6,500 employees.
The shares were at 0.0857 USD on 16 November 2026, down 97.1% over 52 weeks. Its 52-week range is 0.0817 USD to 4.690 USD: the price is 98.2% below the high and 4.9% above the low.
Its market capitalisation is 6.60M USD.
Accendra Health reports return on equity of 238.8%, an operating margin of 0.5% and revenue down 13.7% year over year.
Its debt exceeds its cash by 1.82B USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 25 February 2027.